Bibliographic information

GuidelineMedical eligibility criteria for contraceptive use, 6th ed.
Year of Publication2025
Issuing InstitutionWorld Health Organization

Recommendation

Updated

Women living with severe or advanced HIV clinical disease (WHO stage 3 or 4) who are using Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) should generally not initiate use of the levonorgestrel-intrauterine device

Notes and Remarks

There is no known interaction between ART and IUD use